🇺🇸 FDA
Patent

US 6143719

Bradykinin analogs as selective thrombin inhibitors

expired A61KA61K38/08A61K38/10

Quick answer

US patent 6143719 (Bradykinin analogs as selective thrombin inhibitors) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Nov 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Nov 07 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K38/08, A61K38/10, A61K38/57, A61P